End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- BRL | -.--% | -.--% | -.--% |
May. 16 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Business Summary
Sales per Business
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Insulins
100.0
%
| 105 | 100.0 % | 118 | 100.0 % | +12.62% |
Sales per region
BRL in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brazil
100.0
%
| 105 | 100.0 % | 118 | 100.0 % | +12.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | 19-04-15 | |
Luciano Vilela
CTO | Chief Tech/Sci/R&D Officer | - | 14-02-19 |
Chief Operating Officer | - | - | |
Corporate Officer/Principal | - | - | |
Comptroller/Controller/Auditor | - | - | |
Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 14-01-31 | |
Director/Board Member | 84 | 15-10-12 | |
Director/Board Member | 81 | 13-12-15 | |
Chairman | 80 | 13-12-15 | |
Director/Board Member | - | 15-12-17 | |
Director/Board Member | 85 | 13-12-15 | |
Newton de Souza
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,841,481 | 42,974,062 ( 33.88 %) | 0 | 33.88 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- BIOM3 Stock
- BIOM9 Stock
- Company Biomm S.A.